Wen-Jye Lin, Ph.D. - Publications

Affiliations: 
2003 University of Rochester, Rochester, NY 
Area:
Pathology, Molecular Biology

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Natsagdorj A, Izumi K, Hiratsuka K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Shigehara K, Kadono Y, Lin WJ, Maolake A, Mizokami A. CCL2 Induces Resistance to the Antiproliferative Effect of Cabazitaxel in Prostate Cancer Cells. Cancer Science. PMID 30426599 DOI: 10.1111/cas.13876  0.44
2018 Chen MY, Hsu WC, Hsu SC, Yang YS, Chuang TH, Lin WJ, Tan TH, Su YW. PP4 deficiency leads to DNA replication stress that impairs immunoglobulin class switch efficiency. Cell Death and Differentiation. PMID 30237510 DOI: 10.1038/s41418-018-0199-z  0.6
2017 Urata S, Izumi K, Hiratsuka K, Maolake A, Natsagdorj A, Shigehara K, Iwamoto H, Kadomoto S, Makino T, Naito R, Kadono Y, Lin WJ, Wufuer G, Narimoto K, Mizokami A. CCL5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment. Cancer Science. PMID 29288523 DOI: 10.1111/cas.13494  0.44
2016 Maolake A, Izumi K, Shigehara K, Natsagdorj A, Iwamoto H, Kadomoto S, Takezawa Y, Machioka K, Narimoto K, Namiki M, Lin WJ, Wufuer G, Mizokami A. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Oncotarget. PMID 28039457 DOI: 10.18632/oncotarget.14185  0.44
2015 Izumi K, Mizokami A, Lin HP, Ho HM, Iwamoto H, Maolake A, Natsagdorj A, Kitagawa Y, Kadono Y, Miyamoto H, Huang CK, Namiki M, Lin WJ. Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer. Oncotarget. PMID 26701731 DOI: 10.18632/oncotarget.6690  0.44
2015 Chan PC, Wu CY, Chou LS, Ho CH, Chang CW, Chiou SH, Lin WJ, Chen FD, Chang CA, Hwang JJ, Liu RS, Wang HE. Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 394-402. PMID 25323103 DOI: 10.1007/s11307-014-0774-8  0.4
2014 Lin WJ, Izumi K. Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment. Oncoimmunology. 3: e27871. PMID 25339999 DOI: 10.4161/onci.27871  0.6
2014 Chen MY, Chen YP, Wu MS, Yu GY, Lin WJ, Tan TH, Su YW. PP4 is essential for germinal center formation and class switch recombination in mice. Plos One. 9: e107505. PMID 25215539 DOI: 10.1371/journal.pone.0107505  0.6
2014 Izumi K, Lin WJ, Miyamoto H, Huang CK, Maolake A, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M. Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level. Journal of Cancer Research and Clinical Oncology. 140: 1413-9. PMID 24747988 DOI: 10.1007/s00432-014-1681-8  0.44
2013 Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. Embo Molecular Medicine. 5: 1383-401. PMID 23982944 DOI: 10.1002/emmm.201202367  0.64
2013 Lin TH, Izumi K, Lee SO, Lin WJ, Yeh S, Chang C. Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling. Cell Death & Disease. 4: e764. PMID 23928703 DOI: 10.1038/cddis.2013.270  0.68
2013 Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, Lin WJ, Chang C. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. Cancer Research. 73: 5633-46. PMID 23878190 DOI: 10.1158/0008-5472.CAN-12-3228  0.64
2013 Izumi K, Mizokami A, Lin WJ, Lai KP, Chang C. Androgen receptor roles in the development of benign prostate hyperplasia. The American Journal of Pathology. 182: 1942-9. PMID 23570837 DOI: 10.1016/j.ajpath.2013.02.028  0.64
2012 Lu T, Lin WJ, Izumi K, Wang X, Xu D, Fang LY, Li L, Jiang Q, Jin J, Chang C. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Molecular Endocrinology (Baltimore, Md.). 26: 1707-15. PMID 22915828 DOI: 10.1210/me.2012-1079  0.64
2012 Wang X, Lin WJ, Izumi K, Jiang Q, Lai KP, Xu D, Fang LY, Lu T, Li L, Xia S, Chang C. Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. The Journal of Biological Chemistry. 287: 18376-85. PMID 22474290 DOI: 10.1074/jbc.M112.355164  0.64
2011 Lin WJ, Su YW, Lu YC, Hao Z, Chio II, Chen NJ, Brüstle A, Li WY, Mak TW. Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 108: 18354-9. PMID 22042853 DOI: 10.1073/pnas.1109427108  0.6
2011 Collins LL, Lee YF, Ting HJ, Lin WJ, Liu NC, Meshul CK, Uno H, Bao BY, Chen YT, Chang C. The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice. Reproductive Biology and Endocrinology : Rb&E. 9: 138. PMID 21995792 DOI: 10.1186/1477-7827-9-138  0.6
2011 Lin YY, Chang CH, Li JJ, Stabin MG, Chang YJ, Chen LC, Lin MH, Tseng YL, Lin WJ, Lee TW, Ting G, Chang CA, Chen FD, Wang HE. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Cancer Biotherapy & Radiopharmaceuticals. 26: 373-80. PMID 21711113 DOI: 10.1089/cbr.2010.0906  0.4
2011 Ho CL, Liu IH, Wu YH, Chen LC, Chen CL, Lee WC, Chuang CH, Lee TW, Lin WJ, Shen LH, Chang CH. Molecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice. Journal of Biomedicine & Biotechnology. 2011: 101497. PMID 21660132 DOI: 10.1155/2011/101497  0.4
2011 Lee YF, Liu S, Liu NC, Wang RS, Chen LM, Lin WJ, Ting HJ, Ho HC, Li G, Puzas EJ, Wu Q, Chang C. Premature aging with impaired oxidative stress defense in mice lacking TR4. American Journal of Physiology. Endocrinology and Metabolism. 301: E91-8. PMID 21521714 DOI: 10.1152/ajpendo.00701.2010  0.6
2011 Su YW, Hao Z, Hirao A, Yamamoto K, Lin WJ, Young A, Duncan GS, Yoshida H, Wakeham A, Lang PA, Murakami K, Hermeking H, Vogelstein B, Ohashi P, Mak TW. 14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1. Proceedings of the National Academy of Sciences of the United States of America. 108: 1555-60. PMID 21205887 DOI: 10.1073/pnas.1017729108  0.6
2009 Lai JJ, Lai KP, Chuang KH, Chang P, Yu IC, Lin WJ, Chang C. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. The Journal of Clinical Investigation. 119: 3739-51. PMID 19907077 DOI: 10.1172/JCI39335  0.64
2009 Lin YY, Li JJ, Chang CH, Lu YC, Hwang JJ, Tseng YL, Lin WJ, Ting G, Wang HE. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. Cancer Biotherapy & Radiopharmaceuticals. 24: 453-60. PMID 19694580 DOI: 10.1089/cbr.2008.0572  0.4
2009 Ho CL, Chen LC, Lee WC, Chiu SP, Hsu WC, Wu YH, Yeh CH, Stabin MG, Jan ML, Lin WJ, Lee TW, Chang CH. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice. Cancer Biotherapy & Radiopharmaceuticals. 24: 435-43. PMID 19694578 DOI: 10.1089/cbr.2009.0616  0.4
2009 Liu NC, Lin WJ, Yu IC, Lin HY, Liu S, Lee YF, Chang C. Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling. Endocrine. 36: 211-7. PMID 19618297 DOI: 10.1007/s12020-009-9220-0  0.6
2009 Chang TJ, Chang YJ, Ho TY, Hsiang CY, Yu CY, Lee TW, Lin WJ, Chang CH. Noninvasive bioluminescent and microPET imaging for the regulation of NF-kappaB in human hepatoma-bearing mice. Anticancer Research. 29: 987-94. PMID 19414336  0.4
2009 Liu RS, Chou TK, Chang CH, Wu CY, Chang CW, Chang TJ, Wang SJ, Lin WJ, Wang HE. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model. Nuclear Medicine and Biology. 36: 305-12. PMID 19324276 DOI: 10.1016/j.nucmedbio.2008.12.011  0.4
2009 Chang CW, Lin YY, Peng CJ, Lin M, Liu RS, Wang SJ, Lin WJ, Wang HE. The robotic radiosynthesis of 5-[(18)F]fluoro-2'-deoxyuridine and its biological characterization. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: 1355-61. PMID 19307130 DOI: 10.1016/j.apradiso.2009.02.079  0.4
2008 Chen NJ, Chio II, Lin WJ, Duncan G, Chau H, Katz D, Huang HL, Pike KA, Hao Z, Su YW, Yamamoto K, de Pooter RF, Zúñiga-Pflücker JC, Wakeham A, Yeh WC, et al. Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proceedings of the National Academy of Sciences of the United States of America. 105: 12429-34. PMID 18719121 DOI: 10.1073/pnas.0806585105  0.6
2007 Lee CC, Lin WJ, Shih HI, Wu CJ, Chen PL, Lee HC, Lee NY, Chang CM, Wang LR, Ko WC. Clinical significance of potential contaminants in blood cultures among patients in a medical center. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 40: 438-44. PMID 17932605  0.48
2007 Liu NC, Lin WJ, Kim E, Collins LL, Lin HY, Yu IC, Sparks JD, Chen LM, Lee YF, Chang C. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes. 56: 2901-9. PMID 17827404 DOI: 10.2337/db07-0359  0.64
2007 Chang CW, Chou TK, Liu RS, Wang SJ, Lin WJ, Chen CH, Wang HE. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO). Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 65: 682-6. PMID 17379530 DOI: 10.1016/j.apradiso.2007.01.005  0.4
2005 Chuang KH, Lee YF, Lin WJ, Chu CY, Altuwaijri S, Wan YJ, Chang C. 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor. Molecular Endocrinology (Baltimore, Md.). 19: 1200-12. PMID 15650026 DOI: 10.1210/me.2004-0181  0.64
2005 Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Molecular Endocrinology (Baltimore, Md.). 19: 350-61. PMID 15514032 DOI: 10.1210/me.2004-0190  0.68
2003 Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Research. 63: 7106-12. PMID 14612503  0.68
2003 Lin WJ, Li J, Lee YF, Yeh SD, Altuwaijri S, Ou JH, Chang C. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. The Journal of Biological Chemistry. 278: 9353-60. PMID 12522137 DOI: 10.1074/jbc.M205944200  0.64
2003 Yang Y, Wang X, Dong T, Kim E, Lin WJ, Chang C. Identification of a novel testicular orphan receptor-4 (TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation. The Journal of Biological Chemistry. 278: 7709-17. PMID 12486131 DOI: 10.1074/jbc.M207116200  0.64
2002 Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Cancer Research. 62: 6039-44. PMID 12414626  0.64
2002 Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. The Journal of Biological Chemistry. 277: 43749-56. PMID 12226080 DOI: 10.1074/jbc.M205603200  0.64
2002 Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. The Journal of Biological Chemistry. 277: 36570-6. PMID 12119296 DOI: 10.1074/jbc.M204751200  0.64
Show low-probability matches.